10 Best Under-the-Radar Stocks to Invest In
On July 6, Reuters reported that Morgan Stanley said weakening US semiconductor shares anticipated a broadening market recovery, with investors likely shifting to AI hyperscalers...
Posts Tagged ‘Exelixis Inc. (NASDAQ:EXEL)’
Billionaire Cliff Asness’ Top 10 Healthcare Stock Picks
Cliff Asness is a billionaire investor and the co-founder and chief investment officer of AQR Capital Management, a quantitative hedge fund.
12 Best Stocks to Invest In According to Jim Simons’ Renaissance Technologies
Founded in 1982 by mathematician Jim Simons, Renaissance Technologies is widely regarded as the most successful quantitative hedge fund in financial history.
12 Best Low Priced Growth Stocks to Invest In Now
On May 13, Sébastien Page, T. Rowe Price Head of Global Multi-Asset & CIO, joined CNBC's 'Squawk Box' to discuss navigating a stock market hitting consecutive record highs.
TD Cowen Sees Pipeline Growth Opportunities Supporting Exelixis, Inc. (EXEL) Outlook
TheFly reported on May 6 that EXEL received an updated valuation outlook as TD Cowen increased its price target to $55 from $51 while reaffirming a Buy rating on the stock.
10 Best Cancer Stocks to Buy for the Long Term
Pharmaceutical firms have always had a special place in the healthcare market because they provide stability and expansion.
15 Set-It-and-Forget-It Stocks to Buy in 2026
Long-term wealth building requires choosing investments that could withstand various economic conditions.
Why Exelixis (EXEL) is One of the Best Healthcare Stocks Under $50 to Invest In
Exelixis, Inc. (NASDAQ:EXEL) is one of the best healthcare stocks under $50 to invest in. On February 4, Barclays revised the price target on Exelixis, Inc.
12 Best Healthcare Stocks Under $50 to Invest In
On January 27, Jared Holz, healthcare equity strategist at Mizuho, appeared on CNBC’s 'Power Lunch' to talk about healthcare stocks and the new proposals around Medicare Advantage...
Exelixis, Inc. (EXEL) Sees Mixed Analyst Actions as Zanzalintinib Nears Commercial Launch
TheFly reported on January 8 that H.C.
Top 10 Oncology Stocks to Buy Now
The oncology market in the United States was estimated at $81.34 billion in 2025 and is expected to reach $211.78 billion by 2034 with a compound annual growth rate of 11.75...
Exelixis, Inc. (EXEL) Gets Upgraded to Outperform from Market Perform by Leerink Partners
Exelixis, Inc. (NASDAQ:EXEL) is one of the most profitable biotech stocks to buy. On October 21, Exelixis, Inc.
9 Most Profitable Biotech Stocks to Buy
On October 6, StemPoint Capital CIO Michelle Ross appeared on CNBC’s ‘Closing Bell’ to talk about the biotech space.
Exelixis (EXEL) Loses 12% on Cancer Treatment Trial Results
Exelixis tumbled by 12 percent on Monday to close at $34.54 apiece as unimpressed investors soured on the results of its phase 3 trial for the study of Zanzalintinib for colon...
Exelixis (EXEL) Rated Equalweight by Barclays Amid Cancer Drug Outlook
Exelixis, Inc. (NASDAQ:EXEL) ranks among the most undervalued NASDAQ stocks to buy now. On September 17, Barclays began coverage of Exelixis, Inc.
Morgan Stanley Maintains Overweight Rating For Exelixis, Inc. (EXEL), Price Target Raised To $50
Exelixis, Inc. (NASDAQ:EXEL) is among the Renaissance Technologies Portfolio: 10 Biggest Stocks.
14 Most Undervalued NASDAQ Stocks to Buy Now
On September 22, stocks surged to mark a third consecutive day of record-high closes, driven by hopes that the AI trade and additional Fed policy easing would boost the upward...
Renaissance Technologies Portfolio: 10 Biggest Stocks
The American quant hedge fund is known for using statistical and mathematical tools to drive its investment programs.
Exelixis Appoints Longtime Veteran Dana T. Aftab as Head of R&D
Exelixis Inc. (NASDAQ:EXEL) is one of the best growth stocks to buy for the next 2 years. On August 29, Exelixis Inc. announced the appointment of Dana T.
11 Cheap Biotech Stocks to Buy According to Hedge Funds
Mizuho's Jared Holz appeared on CNBC's "Closing Bell Overtime" on July 8 to talk about whether the biotech industry is prepared for a breakthrough.
H.C. Wainwright Maintains Buy on Exelixis (EXEL) Despite STELLAR-305 Phase 3 Setback
Exelixis, Inc. (NASDAQ:EXEL) is one of the best growth stocks to buy according to analysts. On August 12, H.C.
10 Best Growth Stocks to Buy According to Analysts
Markets have rebounded fast from drawdowns earlier this year.
Exelixis’ CABOMETYX Receives EU Approval for Neuroendocrine Tumor Treatment
Exelixis Inc. (NASDAQ:EXEL) is one of the most undervalued quality stocks to buy according to hedge funds.
12 Most Undervalued Quality Stocks to Buy According to Hedge Funds
On July 31, Nadia Lovell, UBS senior equity strategist, joined 'The Exchange' on CNBC to discuss why she believes this rally has staying power, and to suggest that investors stay...
Exelixis (EXEL) Tumbles 16.8% as Q2 Earnings Disappoint
For the full-year period, Exelixis, Inc.
Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT
Exelixis, Inc. (NASDAQ:EXEL) is one of the most profitable biotech stocks to invest in now.
10 Most Profitable Biotech Stocks to Invest in Now
Jared Holz, Mizuho health care equity strategist, appeared on CNBC’s 'Power Lunch' on March 5 to talk about investing in biotech and the oversaturation in the sector.
Exelixis Gains Analyst Confidence as Cancer Studies Advances
[caption id="attachment_1201235" align="aligncenter" width="1456"] A team of scientists in lab coats surrounded by pharmaceuticals and medical equipment, researching a life-saving...
13 Best Low Risk High Growth Stocks to Buy
The current market is witnessing political chess moves, which are also affecting policy changes.
Stephens Upgrades Exelixis (EXEL) Stock, Raises PT
Exelixis, Inc. (NASDAQ:EXEL) is one of the 10 Unstoppable Stocks to Buy According to Hedge Funds.
10 Unstoppable Stocks to Buy According to Hedge Funds
As per Morgan Stanley, investors can see gains in equities and high-quality fixed income for 2025, despite a slowdown in global economic growth. In the Midyear Investment Outlook...
BofA Hikes Exelixis, Inc. (EXEL) Target Amid CRC Caution
On Thursday, analysts at BofA Securities raised the price target for Exelixis, Inc. (NASDAQ:EXEL) to $46 from $45, with a Neutral rating.
15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies
Even after his passing in 2024, billionaire investor and mathematician Jim Simons remains known as the "Quant King" of hedge funds due to the extraordinary success of Renaissance...
20 Large-Cap Stocks Insiders and Short Sellers Are Dumping Like Crazy
Uncertainty is around every corner of the U.S. stock market, affecting investors’ decisions.
7 Most Profitable Biotech Stocks To Buy Right Now
With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
10 Best Immunology Stocks To Buy Now
Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and pharmaceutical companies.
Renaissance Technologies Portfolio: Top 10 Stock Picks
The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its investment programs.
10 Best Performing Biotech Stocks in 2024
The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.
10 Largest Biotech Hedge Funds and Their Top Stock Picks
The ability to successfully make money through investment requires deep thinking and analysis.
Top 10 Holdings of Caligan Partners
Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds.
Insiders Are Dumping These 10 Healthcare Stocks
In this article, we will take a detailed look at Insiders Are Dumping These 10 Healthcare Stocks. For a quick overview of such stocks, read our article Insiders Are Dumping...
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
10 Biotech Stocks with Huge Potential
In this article, we will take a look at the 10 biotech stocks with huge potential.
10 Mid-Cap Stocks with Insider Purchases
In this article, we will take a detailed look at the 10 Mid-Cap Stocks with Insider Purchases. For a quick overview of such stocks, read our article 5 Mid-Cap Stocks with Insider...
11 Stocks Insiders and Billionaires Are Crazy About
In this article, we will take a detailed look at the 11 Stocks Insiders and Billionaires Are Crazy About. For a quick overview of such stocks, read our article 5 Stocks Insiders...
14 Best Cancer Stocks To Buy Now
In this article, we discuss 14 best cancer stocks to buy.
11 Best Healthcare Stocks Under $50
In this article, we will be taking a look at the 11 best healthcare stocks under $50.
12 Best Biotech Stocks To Buy Under $20
The biotechnology industry is one of the hottest sectors right now, particularly in the aftermath of the coronavirus pandemic since it was this industry that developed messenger...
Hedge Fund Resource Center
